Based on Japan’s Indo-Pacific strategy, explore the development path of China-Japan relations

Japan was the first country to propose the concept of “Indo-Pacific strategy” and was also a staunch supporter and active promoter of it. The formation of Japan’s Indo-Pacific strategy has gone through four stages of evolution: initial appearance, initial formation, extension, and all-round development, and has continuously promoted the development of the Indo-Pacific strategy in a more institutionalized and mature direction from many fields, It has formed a strategic layout in many fields such as comprehensive value sharing, economic and trade competition, maritime security, and multilateral mechanisms. Under the influence of the increasingly fierce competition between China and the US and the policy of putting the United States first, Japan has changed from a proposer of the Indo-Pacific strategy to a promoter, and the Japanese government actively seeks Japan and the United States to jointly dominate the Indo-Pacific economic security order. The accession of the United States has made international relations in the Indo-Pacific region more complex and changeable, and it will have a significant impact on China’s national interests and strategic orientation in the Indo-Pacific area. Sorting out the Japanese Indo-Pacific strategy will help explain the mechanism, rationale, and implementation effect of Japan’s policy choices under the China-US competition, and can also provide a reference for China’s decision-making

Pelvic inflammatory disease in the People's Republic of China: aetiology and management.

OBJECTIVES: To study the causes of pelvic inflammatory disease (PID) in Shenyang, Northeastern China, and to assess the efficacy of the syndromic management flowchart for PID recommended by World Health Organization (WHO). METHODS: 200 outpatients with PID attending Gynaecologic Clinic of No. 1 and No. 2 hospital of China Medical University in Shenyang, and 155 control women without symptoms underwent pelvic examination, and were tested for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (MH), bacterial vaginosis (BV), Candida albicans (CA) and Trichomonas vaginalis (TV). RESULTS: In PID patients, the prevalence of MH was 26%, of BV 26%, of CT 16%, of CA 11%, of TV 4% and of NG 2.5%. In the control population, prevalences were 5.2%, 8.4%, 0%, 5.2%, 0.7%, 0% respectively. MH, BV and CT were significantly more common in PID patients than in controls (P<0.01). One hundred and thirty-seven of the 200 patients with PID (68.5%) returned for follow-up. Symptoms had resolved completely in 64 (47%), and had improved in 68 (50%). There was no improvement in five (4%). CONCLUSIONS: The management protocol for female lower abdominal pain recommended by WHO is effective in this setting